ANAB ANAPTYSBIO, INC

NEUTRAL Impact: 2/10 8-K
Horizon immediate Filed May 29, 2026 Processed 11d 11h ago SEC 0001193125-26-248326
8-K context-dependent: Items 7.01
Latest settled — T+5d
ANAB ▼ -5.21% at T+5d
NEUTRAL call ✗ call lost -5.21% · α vs SPY -2.46% · entry $53.14 → $50.37
Next anchor: T+20d in 19d
Last close $51.36 (close Jun 8) · -3.35% from $53.14 entry
Entry anchored
May 29, 03:59 PM ET
via Databento tick
T+1d
-3.54%
call -3.54% · α -3.69%
$51.26
settled 9d ago
T+5d
-5.21%
call -5.21% · α -2.46%
$50.37
settled 5d ago
T+20d
call — · α —
in 19d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

AnaptysBio filed an 8-K under Item 7.01 to disclose that it has filed Form 8937 with the IRS regarding the tax treatment of the spin-off of First Tracks Biotherapeutics, Inc. The filing provides stockholders with information on how the dividend is treated for tax purposes and how to adjust their tax basis. This is a routine administrative disclosure with no new financial or operational information.

Actionable Insight

No trading signal. The filing is purely informational regarding tax treatment of a prior spin-off. Monitor for any subsequent operational updates from AnaptysBio or First Tracks.

Key Facts

  • AnaptysBio filed Form 8937 with the IRS related to the separation and spin-off of First Tracks Biotherapeutics, Inc.
  • The Form 8937 provides guidance on tax treatment of the dividend and change in tax basis for stockholders.
  • The information is furnished under Regulation FD and is not deemed filed for Exchange Act purposes.

Financial Impact

No financial figures disclosed; tax-basis guidance only.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (18 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-248326
Document: 0001193125-26-248326-index-headers.html0001193125-26-248326
Document: 0001193125-26-248326-index.html0001193125-26-248326
Document: 0001193125-26-248326.txt0001193125-26-248326
15 reports for ANAB
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+60▲ +41.26%Mar 3, 2026
Filters
Rows
Reports for ANAB — sortable, filterable
Type Now
Jun 8, 2026
1d ago
144
BEARISH ★ 5/10
$51.38 awaiting T+1awaiting T+1$51.36 (+0.03%)
Jun 5, 2026
4d ago
144
BEARISH ★ 5/10
$50.58 awaiting T+1awaiting T+1$51.36 (−1.54%)
Jun 5, 2026
4d ago
144
BEARISH ★ 5/10
$51.33 awaiting T+1awaiting T+1$51.36 (−0.06%)
Jun 3, 2026
6d ago
144
BEARISH ★ 5/10
$51.67 $50.37▲ +2.52%▼ −0.08%$51.36 (+0.60%)
Jun 1, 2026
8d ago
144
BEARISH ★ 5/10
$51.26 $51.24▲ +0.04%▼ −0.68%$51.36 (−0.20%)
May 29, 2026
11d ago
8-K
NEUTRAL ★ 2/10
$53.14 $51.26▼ −3.54%▼ −3.69%$51.36 (−3.35%)
May 28, 2026
12d ago
144
NEUTRAL ★ 3/10
$55.67 $53.14▼ −4.54%▼ −4.80%$51.36 (−7.74%)
May 27, 2026
13d ago
144
BEARISH ★ 6/10
$57.02 $55.67▲ +2.37%▲ +2.61%$51.36 (+9.93%)
May 22, 2026
18d ago
144
BEARISH ★ 5/10
$57.77 $57.69▲ +0.14%▲ +0.15%$51.36 (+11.10%)
May 15, 2026
25d ago
144
NEUTRAL ★ 3/10
$58.74 $59.77▲ +1.75%▲ +2.40%$51.36 (−12.56%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 5h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access